Mulmit

Relay Therapeutics, Inc.Relay Therapeutics, Inc.

RLAY Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3115,355,000-302,738,000-276,479,000-1.61
2024-12-3110,007,000-372,468,000-337,708,000-2.36
2023-12-3125,546,000-373,000,000-341,973,000-2.79
2022-12-311,381,000-299,275,000-290,509,000-2.59
2021-12-313,029,000-364,698,000-363,872,000-3.82

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-08Bergstrom Donald APresident, R&D8,530
2026-09-08Catinazzo ThomasChief Financial Officer17,717
2026-09-08Patel SanjivPresident and CEO48,199
2026-08-26Rahmer PeterSee remarks4,508
2026-08-25SVF Pauling (Cayman) Ltd6,000,000
2026-08-17Patel SanjivPresident and CEO48,199
2026-08-14Catinazzo ThomasChief Financial Officer17,717
2026-07-28Catinazzo ThomasChief Financial Officer1,459
2026-07-28Rahmer PeterSee remarks748
2026-07-28Bergstrom Donald APresident, R&D2,237
2026-07-07Patel SanjivPresident and CEO48,199
2026-07-06Bergstrom Donald APresident, R&D8,660

8-K events

FiledItems
2026-08-06Entry into a material agreement · Results of operations · Financial statements and exhibits
2026-06-09Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-21Entry into a material agreement · Financial statements and exhibits
2026-05-19Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-04-27Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-16Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-11Amendments to charter or bylaws · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.